Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
about
Preanalytical Confounding Factors in the Analysis of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease: The Issue of Diurnal VariationImmunity's fourth dimension: approaching the circadian-immune connectionLong-term hydrocephalus alters the cytoarchitecture of the adult subventricular zoneAmyloid β levels in human red blood cellsA consensus in Korea regarding a protocol to reduce preanalytical sources of variability in the measurement of the cerebrospinal fluid biomarkers of Alzheimer's disease.An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter.Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's diseaseComparison of cerebrospinal fluid biomarkers between idiopathic normal pressure hydrocephalus and subarachnoid hemorrhage-induced chronic hydrocephalus: a pilot study.Cortical thickness in relation to clinical symptom onset in preclinical ADNo diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.CSF biomarker changes precede symptom onset of mild cognitive impairmentRelationship of cognitive reserve and cerebrospinal fluid biomarkers to the emergence of clinical symptoms in preclinical Alzheimer's disease.Fingerprint changes in CSF composition associated with different aetiologies in human neonatal hydrocephalus: glial proteins associated with cell damage and loss.Hypothetical Preclinical Alzheimer Disease Groups and Longitudinal Cognitive Change.Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.Linking hypothetical knowledge patterns to disease molecular signatures for biomarker discovery in Alzheimer's disease.Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.Associations Between β-Amyloid Kinetics and the β-Amyloid Diurnal Pattern in the Central Nervous System.Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.Con: Alzheimer's disease and circadian dysfunction: chicken or egg?Cerebrospinal fluid in Alzheimer's: A precious tool.Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years PriorProgressive apraxic agraphia with micrographia presenting as corticobasal syndrome showing extensive Pittsburgh compound B uptake.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease.
P2860
Q26801663-E50A1DE1-B639-4103-A7AF-C737B05D62FAQ26850923-BD457FE3-7AFC-4B27-9265-6EC816BA9095Q30591480-9B3782C7-53FC-4245-BCA1-6D6989EE9A65Q34482602-F6FC6F9A-5D1A-4C65-A2C0-E3D31CFA3195Q35291150-6B7DEC92-967F-4607-9468-1D1358ABDF02Q35899066-42FCF4CF-D70F-4907-A0A4-EE6FE19D5E88Q36240571-21990EF8-DAD8-4E51-BC24-B92CA9611C90Q36337525-758FEC57-9D2E-4492-97A4-F18030EC857DQ36577657-6E1610F2-AFE9-4010-853E-15D8F585C9D0Q37064164-0AA58DC3-BEBD-4EC3-B92F-C4620AE3AC25Q37237233-B99EEACA-3892-46C4-8097-546A31DE6263Q37291572-7535C4E1-208B-47B7-A07E-58ABC1533580Q37295601-6F05CFCA-3283-475C-8292-10281B73D8CBQ37426105-06669DF1-E232-45BB-A8C5-9D17DFDAD306Q37520832-332498CE-7589-4A02-BBCE-CCD94607DDE0Q38037155-4276436F-8C42-4E69-AC6F-924953AA3B0BQ38419506-8ACDF2CB-E191-4D9A-958B-D4A30BA1742BQ38603309-193E2F1A-066C-4F13-8CB7-A1D0485A1FBEQ38780800-859A0993-4710-4258-9DEB-0EC1BB33628AQ41566620-5A0DC3B7-2393-43DC-BF20-6499233F2FAAQ41826789-657A0BB7-8991-43A5-9695-4E0E68684855Q42315799-3672AF11-4BF3-4D9C-81C5-66C9989484EEQ42858923-E346D678-7DE1-42AB-B1B4-AC19CF1CD78BQ44884438-9B92EA43-1838-4815-B448-E719049AE271Q47587631-782D89CB-31CA-4D89-A702-156F23558394Q47610192-0F5C63FA-A855-4873-95BA-78CA4904A4B2
P2860
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
@ast
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
@en
type
label
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
@ast
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
@en
prefLabel
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
@ast
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
@en
P2093
P2860
P1433
P1476
Cerebrospinal fluid Aβ and tau level fluctuation in an older clinical cohort.
@en
P2093
Abhay Moghekar
Richard J O'Brien
P2860
P304
P356
10.1001/ARCHNEUROL.2011.732
P577
2012-02-01T00:00:00Z